These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 7461835)

  • 21. [Comparative study of lipids and lipoprotein metabolism in nephrotic syndrome (author's transl)].
    Shimizu T; Matsumoto H
    Nihon Jinzo Gakkai Shi; 1978 Nov; 20(11):1215-20. PubMed ID: 748643
    [No Abstract]   [Full Text] [Related]  

  • 22. Decreased antioxidant activity in hypercholesterolemic children with nephrotic syndrome.
    Zachwieja J; Bobkowski W; Dobrowolska-Zachwieja A; Zaniew M; Maciejewski J
    Med Sci Monit; 2003 Jun; 9(6):CR235-9. PubMed ID: 12824952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unusually high concentrations of serum lipoprotein(a) in a child with nephrotic syndrome.
    Garnotel R; Roussel B; Monier F; Gillery P
    Clin Nephrol; 1998 Nov; 50(5):334-5. PubMed ID: 9840325
    [No Abstract]   [Full Text] [Related]  

  • 24. Lipoprotein abnormalities in adult nephrotic syndrome.
    Ongajyooth L; Sirisalee K; Laohaphand T; Parichatiganond P; Shayakul C; Nilwarangkur S
    J Med Assoc Thai; 1993 Sep; 76(9):512-20. PubMed ID: 7964258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma lipids and lipoprotein-cholesterol distribution in nephrotic syndrome patients during short term high dose steroid treatment.
    Arije A; Erasmus RT; Anjorin SA
    Cent Afr J Med; 1993 Oct; 39(10):211-5. PubMed ID: 8020077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of simvastatin on lipoprotein (a) and lipoprotein composition in patients with nephrotic syndrome.
    Wanner C; Böhler J; Eckardt HG; Wieland H; Schollmeyer P
    Clin Nephrol; 1994 Mar; 41(3):138-43. PubMed ID: 8187355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Kidney diseases and abnormal lipoprotein metabolism].
    Sasaki J; Arakawa K
    Nihon Rinsho; 1983 Aug; 41(8):1873-7. PubMed ID: 6632299
    [No Abstract]   [Full Text] [Related]  

  • 28. Susceptibility of non-HDL fraction to oxidation in experimental nephrotic syndrome.
    Dirican M; Taş S; Sarandöl E; Tokullugil HA
    Kobe J Med Sci; 1998 Dec; 44(5-6):235-45. PubMed ID: 10401226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipoprotein(a) predicts the risk of thrombogenic complications in nephrotic syndrome.
    Fujita T; Saito E; Ohi H; Yasugi T; Hatano M
    Nephron; 1992; 61(1):122. PubMed ID: 1388249
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cholesterol metabolism in children with idiopathic nephrotic syndrome].
    Stozický F; Liska J; Dobiásová M; Slovácek R
    Cesk Pediatr; 1988 Jun; 43(6):323-6. PubMed ID: 3401965
    [No Abstract]   [Full Text] [Related]  

  • 31. Prognostic significance of serum cholesterol in childhood nephrotic syndrome.
    Okoro BA
    East Afr Med J; 1987 Dec; 64(12):845-8. PubMed ID: 3505207
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies on the metabolism of plasma proteins in the nephrotic syndrome. II. The lipoproteins.
    GITLIN D; CORNWELL DG; NAKASATO D; ONCLEY JL; HUGHES WL; JANEWAY CA
    J Clin Invest; 1958 Feb; 37(2):172-84. PubMed ID: 13513748
    [No Abstract]   [Full Text] [Related]  

  • 33. Pathogenesis of lipid abnormalities in patients with nephrotic syndrome/proteinuria: clinical implications.
    Warwick GL; Packard CJ
    Miner Electrolyte Metab; 1993; 19(3):115-26. PubMed ID: 8232098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of apoprotein epsilon 2 homozygosity on nephrotic hyperlipidemia.
    Joven J; Vilella E
    Clin Nephrol; 1997 Sep; 48(3):141-5. PubMed ID: 9342484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Electrophoretic study of serum lipoproteins. I. Study of serum lipoproteins in nephrotic syndrome].
    Taskovska D; Kotevska P; Markovik O; Tasevska S; Radenkova M
    God Zb Med Fak Skopje; 1969; 15():267-77. PubMed ID: 5199996
    [No Abstract]   [Full Text] [Related]  

  • 36. [Protein & lipoprotein electrophoretic picture of the serum in nephrotic syndrome of childhood, with special reference to changes observed in the course of treatment with ACTH & prednisone].
    SALTERI F; ZEVI E
    Minerva Pediatr; 1958 Feb; 10(8):185-200. PubMed ID: 13541154
    [No Abstract]   [Full Text] [Related]  

  • 37. The effects of gemfibrozil on hyperlipidemia in children with persistent nephrotic syndrome.
    Büyükçelik M; Anarat A; Bayazit AK; Noyan A; Ozel A; Anarat R; Aydingülü H; Dikmen N
    Turk J Pediatr; 2002; 44(1):40-4. PubMed ID: 11858378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship among the concentrations of serum lipoproteins and changes in their chemical composition in patients with untreated nephrotic syndrome.
    Gherardi E; Rota E; Calandra S; Genova R; Tamborino A
    Eur J Clin Invest; 1977 Dec; 7(6):563-70. PubMed ID: 415877
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
    Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T
    Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoprotein(a) in patients with the nephrotic syndrome: influence of immunosuppression and proteinuria.
    Wanner C; Bartens W; Nauck M; Zäuner I; Greiber S; Schollmeyer P
    Miner Electrolyte Metab; 1996; 22(1-3):26-30. PubMed ID: 8676820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.